Role of the Immune System in Preventing Laryngeal Cancer
NCT07508319 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2026-04-02
Summary
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation
Conditions
- Head & Neck Cancer
Sponsors & Collaborators
-
European Institute of Oncology
lead OTHER
Principal Investigators
-
Marta Tagliabue, MD · Istituto Europeo di Oncologia
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-19
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Italy
Study Locations
More Related Trials
-
IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate
NCT05293327 ·Status: UNKNOWN
-
Biospecimen Procurement for Head and Neck Disorders
NCT03429036 ·Status: RECRUITING
-
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
NCT05522881 ·Status: RECRUITING
-
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
NCT05832593 ·Status: UNKNOWN
-
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
NCT05791149 ·Status: RECRUITING ·Phase: NA
-
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
NCT05014698 ·Status: TERMINATED ·Phase: NA
-
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
NCT05880797 ·Status: RECRUITING
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219 ·Status: RECRUITING
-
Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer
NCT06706973 ·Status: RECRUITING
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
NCT04085900 ·Status: RECRUITING
-
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
NCT00341146 ·Status: COMPLETED
-
Comparison of Immune Response Following Surgical Management of Renal Tumors
NCT00289146 ·Status: TERMINATED
-
Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
NCT00393224 ·Status: TERMINATED
-
Microbiome in Head and Neck Squamous Cell Carcinoma
NCT05837221 ·Status: RECRUITING
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
NCT02095912 ·Status: COMPLETED
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733 ·Status: COMPLETED
-
Proteome- and Methylation Profiles in Oropharyngeal Cancer
NCT04567082 ·Status: COMPLETED
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer
NCT02365844 ·Status: COMPLETED